ETON
Eton Pharmaceuticals, Inc.Company with tickers: ETON
CIK
1710340
CUSIP
29772L108
Shares Outstanding
27,392,358
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $17,282,000 | USD | 2025-03-31 | 10-Q | 2026-05-14 |
| Cost of Revenue | — | ||||
| Gross Profit | $9,861,000 | USD | 2025-03-31 | 10-Q | 2026-05-14 |
| Operating Expenses | $10,331,000 | USD | 2025-03-31 | 10-Q | 2026-05-14 |
| Research & Development | $1,161,000 | USD | 2025-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $-470,000 | USD | 2025-03-31 | 10-Q | 2026-05-14 |
| Net Income | $-1,572,000 | USD | 2025-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $-0.06 | USD/shares | 2025-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | $-0.06 | USD/shares | 2025-03-31 | 10-Q | 2026-05-14 |